Matters of the heart
The heart, and how to fix it when it is no longer working, has been an important area for us at Novartis. It has been the focus of our research and commitment, where we’ve won awards, where we are striving forwards in the discovery of new management options, and most importantly where we have seen the huge impact of our work on the lives of patients.
According to the World Health Organization, cardiovascular disease is the number one cause of death globally1. Eclipsing starvation and infectious diseases as the most critical health concern, cardiovascular disease poses a serious threat - one that cannot be ignored.
We started our quest into helping people with cardiovascular disease over 60 years ago. Since then, we have been committed to reimagining the standard of care for some of these progressive and potentially life-threatening cardiovascular conditions, and we remain steadfast in that commitment to this day.
Our commitment to research into heart failure
Heart failure is a complex, debilitating and potentially life-threatening condition where the heart cannot pump enough blood around the body. This leaves patients fatigued and short of breath, with a diminished quality of life and at risk of hospitalization or sudden cardiac death.
There are currently at least 26 million people worldwide living with heart failure2. It is estimated that 83 percent of patients with heart failure are hospitalized due to an acute heart failure episode at least once, and nearly half (43 percent) are hospitalized at least four times3. Hospitalization of patients with heart failure represents a short-term risk of death or being re-admitted to the hospital and as such is an important area of research for Novartis.
Heart failure represents a major health-economic burden that currently costs the world economy an estimated $108 billion every year in both direct and indirect costs4. It is therefore not surprising that in 1997 heart failure was singled out as an emerging epidemic.
Our research has been focused on directly addressing the heart beyond the symptoms and co-morbidities of heart failure.